rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    CTKB
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Stephens raises Cytek Biosciences stock price target on margin gains
      Nov 10Investing.comCTKB
      Piper Sandler Remains a Buy on Cytek Biosciences (CTKB)

      Tipranks Press Release.

      Nov 6The Globe and MailCTKB
      Cytek Biosciences, Inc. Q3 2026 Earnings Call Summary
      Nov 5Yahoo FinanceCTKB
      Cytek Biosciences Inc (CTKB) Q3 2026 Earnings Call Highlights: U.S. ...
      Nov 5Yahoo FinanceCTKB
      Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates
      Nov 4Yahoo FinanceCTKB
      Cytek Biosciences Q3 Earnings Call Highlights
      Nov 4Yahoo FinanceCTKB
      Cytek Biosciences Q3 2026 Earnings Call Transcript
      Nov 4BenzingaCTKB
      Cytek Biosciences Reports Third Quarter 2026 Financial Results
      Nov 4Yahoo FinanceCTKB
      Cytek Biosciences to Participate in Upcoming Investor Conferences
      Oct 29Yahoo FinanceCTKB
      Analysts Estimate Cytek Biosciences, Inc. (CTKB) to Report a Decline in Earnings: What to Look Out for
      Oct 28Yahoo FinanceCTKB
      Cytek Biosciences (CTKB) Stock Sees Modest Fair Value Lift As Analysts Weigh Profitability
      Oct 25Yahoo FinanceCTKB
      Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026
      Oct 21Yahoo FinanceCTKB
      Fund Divests Cytek Biosciences (CTKB) Following Revenue Slowdown and Declining Profitability
      Sep 29Yahoo FinanceCTKB
      Cytek Biosciences launches cloud-based analysis tool
      Sep 23Investing.comCTKB
      Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
      Sep 23Yahoo FinanceCTKB
      Is the Options Market Predicting a Spike in Cytek Biosciences Bank Stock?

      Investors need to pay close attention to CTKB stock based on the movements in the options market lately.

      Sep 17Yahoo FinanceCTKB
      Cytek at Morgan Stanley global healthcare conference: growth broadens
      Sep 16Investing.comCTKBMS
      Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry

      Complementary Technologies Deliver an Integrated, End-to-End Clinical Flow Cytometry Workflow for Laboratories Across Europe Cytek Biosciences and Sysmex Europe Collaborate Cytek Biosciences and Sysmex Europe have signed an agreement establishing a strategic collaboration to enhance clinical flow cytometry workflows and expand access to innovative diagnostic solutions. By combining their complementary technologies, the collaboration will provide an integrated, end-to-end clinical flow cytometry

      Sep 9Yahoo FinanceCTKB
      Cytek Biosciences, Sysmex Europe Collaborate to Deliver Clinical Flow Cytometry Workflows

      Cytek Biosciences (CTKB) and diagnostic and healthcare provider Sysmex Europe said Wednesday they ar

      Sep 9Yahoo FinanceCTKB
      Cytek’s (CTKB) Instruments Keep Selling While Losses Keep Growing

      On August 5, Cytek Biosciences (NASDAQ:CTKB) reported financial results for the second quarter ended June 30, and the report reads like two different companies at once. Revenue climbed, margins widened, and the installed base of instruments kept expanding. At the same time, the net loss more than doubled from a year earlier and adjusted EBITDA […]

      Sep 9Yahoo FinanceCTKB
      Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS

      FREMONT, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- As clinical laboratories seek deeper cellular insights, greater efficiency, and more streamlined approaches to cell analysis, spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) will showcase its advanced solutions at two leading clinical cytometry events this fall: the European Society for Clinical Cell Analysis (ESCCA) 2026 Conference and ICCS 2026, the 41st Annual International Clinical Cytometry Meeting & Course. Set apart

      Sep 3Yahoo FinanceCTKB
      Cytek Biosciences to Participate in Upcoming Investor Conferences

      FREMONT, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences.Wells Fargo 21st Annual Healthcare Conference in Boston, MACFO William McCombe will be participating in investor meetings on Tuesday, September 8, 2026Morgan Stanley 24th Annual Global Healthcare Conference in New York, NYCEO Wenbin Jiang and CFO William McCombe will be partic

      Sep 1Yahoo FinanceCTKB
      Cytek Biosciences wins on three of four patent claims
      Aug 21Investing.comCTKB
      Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding

      FREMONT, Calif., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences,” “Cytek,” or the “Company”) (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that a jury in the United States District Court for the District of Delaware returned a verdict in the patent infringement action brought by Beckman Coulter, Inc. The jury found in Cytek’s favor on three of the four asserted patent claims, finding noninfringement and invalidity as to each of those th

      Aug 21Yahoo FinanceCTKB
      Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
      Aug 21ReutersCTKBDHR

      This is the newest page. Registered accounts read further back.